What Parents Should Know About the DTaP Vaccine for Children

The DTaP vaccine protects your child from three dangerous infections. Five doses are required, administered between birth and 6 years of age.

DTaP safeguards against diphtheria, tetanus, and pertussis (whooping cough).

“This vaccine helps prevent three extremely dangerous infectious diseases, which have now been effectively controlled since its introduction,” says Dr. Chandani Dezure, a pediatrician in Palo Alto, California, a neonatology and pediatric hospitalist, and member of the BabyCenter Medical Advisory Board. “However, with declining vaccination rates, even pertussis has resurged in developed countries.”

Three vaccines target these diseases, administered based on age:

• DTaP is for young children.
• Tdap is for adolescents aged 11–12, adults who haven’t received a booster, and pregnant individuals to protect infants. It is a lower-dose booster of DTaP.
• Tetanus-diphtheria (Td) vaccine is for children aged 7 and older and adults, containing only tetanus and diphtheria components. Adults are advised to get a booster every 10 years.

What Diseases Does DTaP Prevent?

DTaP protects children from three potentially severe illnesses:

• Diphtheria: A highly contagious bacterial infection spread via droplets or contaminated objects. Infected individuals can transmit the disease even without symptoms. After fever and sore throat, a gray coating may form in the throat, causing breathing and swallowing difficulties, and severe cases can lead to suffocation. Untreated, bacterial toxins may damage tissues throughout the body, resulting in heart failure or paralysis.The CDC notes diphtheria has a 20% mortality rate in children under 5 and adults over 40. Before the vaccine’s introduction in the 1920s, it was a leading cause of child deaths globally, with over 175,000 cases annually in the U.S. While now controlled in the U.S. (only rare cases in international travelers since 1997), diphtheria remains prevalent in Eastern Europe, the Middle East, the South Pacific, Haiti, and the Dominican Republic. Thus, exposure via air travel is possible despite low U.S. risk.
• Tetanus: A bacterial infection causing muscle spasms, seizures, and paralysis, with severe cases leading to difficulty swallowing, breathing, or death. The CDC reports a 10% mortality rate for generalized tetanus despite intensive care. Tetanus is not contagious, but bacteria in soil and dust enter the body through skin wounds (e.g., punctures, burns).Widespread use of the tetanus vaccine in the U.S. since the 1940s has reduced cases by over 95%, with fewer than 50 annual reports. However, in developing countries with limited access to vaccines, tetanus remains a leading cause of newborn deaths.
• Pertussis (whooping cough): A highly contagious bacterial disease and preventable childhood illness. Severe coughing fits disrupt eating, drinking, and breathing, potentially leading to pneumonia, seizures, brain damage, or death. Since the vaccine’s U.S. introduction in the 1940s, cases have dropped by over 90% (from over 200,000 annually, a leading child killer).Pertussis remains a major threat to children globally. U.S. cases have risen since the 1980s, with 35,435 reported in 2024—far exceeding 2023’s 7,063. DTaP effectively protects children, while adult vaccination helps safeguard infants and other children.

Dr. Dezure emphasizes: “It’s crucial for siblings and caregivers of newborns to be fully vaccinated against pertussis, as newborns face the highest risk of severe illness or death from it.”

Recommended DTaP Vaccination Schedule

• Doses:
  • 5 doses of DTaP between birth and 6 years.
  • 1 dose of Tdap at 11–12 years (adolescents who missed childhood doses can catch up).
  • 1 dose of Tdap for unvaccinated adolescents, adults, and pregnant individuals.
  • After Tdap, adults should get a Td or Tdap booster every 10 years.
• Recommended ages:
  • 2 months
  • 4 months
  • 6 months
  • 15–18 months
  • 4–6 years
  • 11 or 12 years (Tdap booster)

DTaP can be administered alone or with other vaccines. Consult a doctor for catch-up schedules if delayed.

Who Should Not Receive DTaP?

Infants under 6 weeks old should not receive DTaP. If a child had a severe reaction to a previous dose, consult a doctor. Healthcare providers will assess safety or recommend alternatives (e.g., DT vaccine for children over 7 if the pertussis component caused a reaction).

Precautions

Children with moderate to severe illnesses should wait until recovery to vaccinate. Those with mild illnesses (e.g., colds) can still be immunized.

Possible Side Effects

Most side effects are mild, often linked to the pertussis component. Common reactions include redness, swelling, or pain at the injection site, mild fever, fussiness, fatigue, or vomiting. For discomfort, consult a doctor about acetaminophen or ibuprofen (for children over 6 months). A warm compress may ease injection site pain.

Severe reactions are rare but possible, including allergic reactions, seizures, nonstop crying for 3+ hours, or high fever (over 105°F).

Key Points

• DTaP protects against diphtheria, tetanus, and pertussis.
• 5 doses are needed between birth and 6 years, with a Tdap booster at 11–12 years.
• Unvaccinated adolescents, adults, and pregnant individuals should get 1 dose of Tdap, followed by Td or Tdap boosters every 10 years.